Incidence and mortality of alcohol-related dementia and Wernicke-Korsakoff syndrome: A nationwide register study.


Journal

International journal of geriatric psychiatry
ISSN: 1099-1166
Titre abrégé: Int J Geriatr Psychiatry
Pays: England
ID NLM: 8710629

Informations de publication

Date de publication:
08 2022
Historique:
received: 24 03 2022
accepted: 20 06 2022
pubmed: 6 7 2022
medline: 7 7 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Epidemiological data on alcohol-related cognitive disorders are scarce. Up-to-date population-based incidence and mortality rates for Wernicke-Korsakoff syndrome (WKS) and alcohol-related dementia (ARD) are necessary to understand the burden of these diseases. We collected diagnostic data from the Finnish Hospital Discharge Register and mortality data from Statistics Finland for all persons aged ≥40 years who had received a diagnosis of WKS (n = 1149) or ARD (n = 2432) between 1998 and 2015 in Finland. We calculated the incidences and mortality in relation to the age-, sex- and calendar year-matched general population. Causes of death were ascertained from death certificates. For WKS, the incidence per 100,000 person-years (95% confidence interval (CI)) was 3.7 (3.4-3.9) in men and 1.2 (1.1-1.3) in women. For ARD, the incidence was 8.2 (7.9-8.6) in men and 2.1 (1.9-2.3) in women. The incidence of WKS peaked in people aged 50-59 years and the incidence of ARD in people aged 70-79 years. The standardized mortality ratio (95% CI) was 5.67 (5.25-6.13) in WKS patients and 5.41 (5.14-5.70) in ARD patients. Most of the excess mortality resulted from alcohol-related causes. To our knowledge, this is the first study describing population-based incidence and mortality rates, sex-segregated data and causes of death in patients with WKS or ARD. Our results establish a point of reference for the incidence of WKS and ARD and show the high mortality and poor prognosis of these disorders.

Sections du résumé

BACKGROUND
Epidemiological data on alcohol-related cognitive disorders are scarce. Up-to-date population-based incidence and mortality rates for Wernicke-Korsakoff syndrome (WKS) and alcohol-related dementia (ARD) are necessary to understand the burden of these diseases.
METHODS
We collected diagnostic data from the Finnish Hospital Discharge Register and mortality data from Statistics Finland for all persons aged ≥40 years who had received a diagnosis of WKS (n = 1149) or ARD (n = 2432) between 1998 and 2015 in Finland. We calculated the incidences and mortality in relation to the age-, sex- and calendar year-matched general population. Causes of death were ascertained from death certificates.
RESULTS
For WKS, the incidence per 100,000 person-years (95% confidence interval (CI)) was 3.7 (3.4-3.9) in men and 1.2 (1.1-1.3) in women. For ARD, the incidence was 8.2 (7.9-8.6) in men and 2.1 (1.9-2.3) in women. The incidence of WKS peaked in people aged 50-59 years and the incidence of ARD in people aged 70-79 years. The standardized mortality ratio (95% CI) was 5.67 (5.25-6.13) in WKS patients and 5.41 (5.14-5.70) in ARD patients. Most of the excess mortality resulted from alcohol-related causes.
CONCLUSIONS
To our knowledge, this is the first study describing population-based incidence and mortality rates, sex-segregated data and causes of death in patients with WKS or ARD. Our results establish a point of reference for the incidence of WKS and ARD and show the high mortality and poor prognosis of these disorders.

Identifiants

pubmed: 35789035
doi: 10.1002/gps.5775
pmc: PMC9546078
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.

Références

J Basic Clin Physiol Pharmacol. 2018 Oct 2;30(2):153-162
pubmed: 30281514
Psychosomatics. 2017 Jul - Aug;58(4):331-342
pubmed: 28501289
Alzheimers Dement. 2019 Jul;15(7):917-926
pubmed: 31175028
J Neurol Neurosurg Psychiatry. 1983 Jul;46(7):593-8
pubmed: 6886695
Alzheimers Dement. 2017 Jan;13(1):28-37
pubmed: 27172148
Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):203-5
pubmed: 21192236
Br J Psychiatry. 1998 Jul;173:11-53
pubmed: 9850203
Alcohol Alcohol. 1997 May-Jun;32(3):281-5
pubmed: 9199729
Scand J Public Health. 2012 Aug;40(6):505-15
pubmed: 22899561
Clin Pract Epidemiol Ment Health. 2013 Jun 14;9:88-95
pubmed: 23878613
Acta Psychiatr Scand. 1987 Jun;75(6):604-7
pubmed: 3618282
Neuropsychiatr Dis Treat. 2017 Nov 27;13:2875-2890
pubmed: 29225466
J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):341-5
pubmed: 3701343
Alzheimers Res Ther. 2013 Jan 25;5(1):3
pubmed: 23347747
Psychosomatics. 2012 Nov-Dec;53(6):507-16
pubmed: 23157990
Lancet. 2009 Feb 7;373(9662):492-501
pubmed: 19168210
Alzheimers Res Ther. 2019 Jan 5;11(1):1
pubmed: 30611304
Eur J Neurol. 2010 Dec;17(12):1408-18
pubmed: 20642790
J Am Geriatr Soc. 2001 Apr;49(4):415-20
pubmed: 11347785
Exp Clin Psychopharmacol. 2002 Aug;10(3):193-212
pubmed: 12233981
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1206-9
pubmed: 12933919
Acta Psychiatr Scand. 2015 Apr;131(4):297-306
pubmed: 25243359
Alcohol Alcohol. 1998 Jul-Aug;33(4):317-36
pubmed: 9719389
Mayo Clin Proc. 2017 Jun;92(6):899-907
pubmed: 28578781
Int J Geriatr Psychiatry. 1998 Apr;13(4):203-12
pubmed: 9646147
Forensic Sci Int. 2001 Jan 1;115(1-2):15-32
pubmed: 11056267
Aust N Z J Psychiatry. 2011 Nov;45(11):985-92
pubmed: 21961480
Int Psychogeriatr. 2014 Jan;26(1):115-21
pubmed: 24308344
Alcohol Alcohol. 2017 Jul 01;52(4):466-471
pubmed: 28340112
Contemp Neurol Ser. 1971;7:1-206
pubmed: 5162155
Alcohol Clin Exp Res. 1994 Dec;18(6):1330-4
pubmed: 7695026
Addiction. 2013 Sep;108(9):1562-78
pubmed: 23627868
Int J Geriatr Psychiatry. 2022 Aug;37(8):
pubmed: 35789035
Postgrad Med J. 1991 Nov;67(793):978-81
pubmed: 1775421
Geriatr Gerontol Int. 2020 Nov;20(11):1050-1055
pubmed: 32989857
J Neurol Sci. 1982 Nov;56(2-3):233-48
pubmed: 7175549

Auteurs

Anniina Palm (A)

Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Risto Vataja (R)

Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Tiina Talaslahti (T)

Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Milena Ginters (M)

Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Hannu Kautiainen (H)

Primary Health Care Unit, Kuopio University Hospital, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.

Henrik Elonheimo (H)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Jaana Suvisaari (J)

Finnish Institute for Health and Welfare, Helsinki, Finland.
Mental Health Unit, Helsinki, Finland.

Nina Lindberg (N)

Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Hannu Koponen (H)

Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH